Skip to main content
Fig. 3 | BMC Endocrine Disorders

Fig. 3

From: Enhancement of postprandial endogenous insulin secretion rather than exogenous insulin injection ameliorated insulin antibody-induced unstable diabetes: a case report

Fig. 3

Diurnal C-peptide levels before and 2 h after each meal and C-peptide responses to each meal when given liraglutide 0.9 mg before breakfast, voglibose 0.2 mg before lunch and insulin lispro 3 U before each meal at the 54th day after hospitalization (white circle or bar) and liraglutide 0.9 mg before breakfast, voglibose 0.2 mg before lunch and mitiglinide 10 mg before each meal at the 59th day after hospitalization (black circle or bar)

The data on C-peptide responses to each meal are presented as postprandial C-peptide increments ± SD (n = 3). **, P < 0.01. The results of comparisons of treatments were assessed employing the unpaired t-test

Back to article page